Table 3.
Linear Regression Predicting Moxifloxacin Minimum Inhibitory Concentration
Covariate | Fold Increase in MIC | SE | 95% CI | P Value |
---|---|---|---|---|
Linear Regression Predicting Moxifloxacin MIC (n = 480) | ||||
Fluoroquinolone use at presentation | 2.01 | 1.21 | 1.39–2.91 | <.001 |
Linear Regression Predicting Moxifloxacin MIC, Controlling for Organism (n = 480) | ||||
Fluoroquinolone use at presentation | 1.38 | 0.19 | 0.08–0.84 | .02 |
Linear Regression Predicting Moxifloxacin MIC by Fluoroquinolone Generation (n = 480) | ||||
Second-generation fluoroquinolone use | 1.47 | 1.27 | 0.93–1.33 | .10 |
Third-generation fluoroquinolone use | 1.68 | 2.22 | 0.35–8.11 | .51 |
Fourth-generation fluoroquinolone use | 3.48 | 1.33 | 1.99–6.06 | <.001 |
Abbreviation: MIC, minimum inhibitory concentration.